Literature DB >> 21830898

Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection.

Itta Krishna Chaaitanya1, Nagarajan Muruganandam, Senthil G Sundaram, Omkar Kawalekar, Attayur P Sugunan, Sathya P Manimunda, Sruti R Ghosal, Karuppiah Muthumani, Paluru Vijayachari.   

Abstract

Chikungunya virus (CHIKV) has caused large outbreaks worldwide in recent years. Acute-phase CHIKV infection has been reported to cause mild to severe febrile illness, and in some patients, this may be followed by long-lasting polyarthritis. The mainstay of treatment includes nonsteroidal anti-inflammatory drugs and other disease-modifying agents, the use of which is based on the assumption of an immunological interference mechanism in the pathogenesis. The present study has been designed to generate preliminary evidence to test this hypothesis. The levels of 30 cytokines were estimated in serum samples of acute CHIKV-infected patients, fully-recovered patients, patients with chronic CHIKV arthritis, and controls, using a quantitative multiplex bead ELISA. The levels of the proinflammatory cytokines IL-1 and IL-6 were elevated in acute patients, but IFN-γ/β and TNF-α levels remained stable. IL-10, which might have an anti-inflammatory effect, was also elevated, indicating a predominantly anti-inflammatory response in the acute phase of infection. Elevation of MCP-1, IL-6, IL-8, MIP-1α, and MIP-1β was most prominent in the chronic phase. These cytokines and chemokines have been shown to play important roles in other arthritides, including epidemic polyarthritis (EPA) caused by Ross River virus (RRV) and rheumatoid arthritis (RA).The immunopathogenesis of chronic CHIKV arthritis might have similarities to these arthritides. The novel intervention strategies being developed for EPA and RA, such as IL-6 and IL-8 signaling blockade, may also be considered for chronic CHIKV arthritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830898     DOI: 10.1089/vim.2010.0123

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  49 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Would be IL-6 a missing link between chronic inflammatory rheumatism and depression after chikungunya infection?

Authors:  Alfonso J Rodriguez-Morales; Karol Liceth Hoyos-Guapacha; Sara Lucia Vargas-Zapata; Oscar Mauricio Meneses-Quintero; Julio César Gutiérrez-Segura
Journal:  Rheumatol Int       Date:  2017-05-26       Impact factor: 2.631

Review 4.  Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common.

Authors:  J Kennedy Amaral; Joshua B Bilsborrow; Robert T Schoen
Journal:  Am J Med       Date:  2019-11-06       Impact factor: 4.965

Review 5.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 6.  Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology.

Authors:  Teck-Hui Teo; Fok-Moon Lum; Wendy W L Lee; Lisa F P Ng
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

7.  Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid.

Authors:  Aileen Y Chang; Karen A O Martins; Liliana Encinales; St Patrick Reid; Marlon Acuña; Carlos Encinales; Christian B Matranga; Nelly Pacheco; Carlos Cure; Bhavarth Shukla; Teofilo Ruiz Arteta; Richard Amdur; Lisa H Cazares; Melissa Gregory; Michael D Ward; Alexandra Porras; Alejandro Rico Mendoza; Lian Dong; Tara Kenny; Ernie Brueggemann; Lydia G Downey; Priyanka Kamalapathy; Paola Lichtenberger; Orlando Falls; Gary L Simon; Jeffrey M Bethony; Gary S Firestein
Journal:  Arthritis Rheumatol       Date:  2018-03-07       Impact factor: 10.995

8.  Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.

Authors:  Vinod Ravindran; George Alias
Journal:  Clin Rheumatol       Date:  2016-10-04       Impact factor: 2.980

9.  Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss.

Authors:  Weiqiang Chen; Suan-Sin Foo; Nestor E Rulli; Adam Taylor; Kuo-Ching Sheng; Lara J Herrero; Belinda L Herring; Brett A Lidbury; Rachel W Li; Nicole C Walsh; Natalie A Sims; Paul N Smith; Suresh Mahalingam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

10.  The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infection.

Authors:  Robert L Seymour; Shannan L Rossi; Nicholas A Bergren; Kenneth S Plante; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2013-04-08       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.